Related Experiment Video
Updated: May 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis
Jurgen R Piet1, Matthijs C Brouwer, Rachel Exley
1Department of Neurology, Center of Infection and Immunity Amsterdam-CINIMA, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Abstract:
Factor H Binding protein (fHbp) is an important meningococcal virulence factor, enabling the meningococcus to evade the complement system, and a main target for vaccination. Recently, the structure of fHBP complexed with factor H (fH) was published. Two fHbp glutamic acids, E(283) and E(304), form salt bridges with fH, influencing interaction between fHbp and fH. Fifteen amino acids were identified forming hydrogen bonds with fH. We sequenced fHbp of 254 meningococcal isolates from adults with meningococcal meningitis included in a prospective clinical cohort to study the effect of fHbp variants on meningococcal disease severity and outcome. All fHbp of subfamily A had E304 substituted with T304. Of the 15 amino acids in fHbp making hydrogen bonds to fH, 3 were conserved, 11 show a similar distribution between the two fHbp subfamilies as the polymorphism at position 304. The proportion of patients infected with meningococci with fHbp of subfamily A with unfavorable outcome was 2.5-fold lower than that of patients infected with meningococci with fHbp of subfamily B (2 of 40 (5%) vs. 27 of 213 (13%) (P = 0.28). The charge of 2 of 15 amino acids (at position 184 and 306) forming hydrogen bonds was either basic or acidic. The affinity of fHbp(K184) and of fHbp(D184) for recombinant purified human fH was assessed by Surface Plasmon Resonance and showed average K(D) of 2.60×10(-8) and 1.74×10(-8), respectively (ns). Patients infected with meningococci with fHbp(D184) were more likely to develop septic shock during admission (11 of 42 [26%] vs. 19 of 211 [9%]; P = 0.002) resulting in more frequent unfavorable outcome (9 of 42 [21%] vs. 20 of 211 [10%]; P = 0.026). In conclusion, we dentified fHBP(D184) to be associated with septic shock in patients with meningococcal meningitis.
Insights
Factor H Binding protein (fHbp) variants impact meningococcal disease. The fHbp(D184) variant is linked to increased risk of septic shock and unfavorable outcomes in patients with meningococcal meningitis.
Area of Science:
- Microbiology
- Immunology
- Genetics
Background:
- Factor H Binding protein (fHbp) is a key meningococcal virulence factor that helps bacteria evade the complement system.
- fHbp is a primary target for meningococcal vaccines.
- Structural studies revealed interactions between fHbp and complement factor H (fH), involving specific amino acid residues like E(283) and E(304).
Purpose of the Study:
- To investigate the impact of fHbp variants on the severity and outcomes of meningococcal meningitis.
- To analyze the correlation between specific fHbp genetic variations and clinical manifestations.
- To understand how fHbp polymorphisms influence the interaction with human factor H.
Main Methods:
- Sequencing of fHbp from 254 meningococcal isolates from adult patients with meningitis.
- Analysis of clinical data including disease severity and patient outcomes.
- Assessment of fHbp-fH binding affinity using Surface Plasmon Resonance for specific variants (e.g., fHbp(K184) and fHbp(D184)).
Main Results:
- fHbp subfamily A isolates showed a substitution of E304 with T304.
- Patients infected with meningococci expressing fHbp subfamily A had a lower proportion of unfavorable outcomes compared to subfamily B.
- The fHbp(D184) variant was significantly associated with a higher likelihood of developing septic shock (26% vs. 9%) and unfavorable outcomes (21% vs. 10%) in patients.
Conclusions:
- Specific fHbp variants, particularly fHbp(D184), are associated with increased disease severity in meningococcal meningitis.
- The identified fHbp variants influence the interaction with factor H, potentially affecting complement evasion.
- Understanding these fHbp-host interactions is crucial for developing effective vaccines and treatments against meningococcal disease.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
10:55Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
Published on: October 16, 2018
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Bacterial Meningitis II: Pathophysiology
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Bacterial Meningitis I: Introduction